Trial intelligence / Profile preview

New Neonatal Dobutamine Formulation for Haemodynamic Insufficiency

NCT03311178Phase 2Terminated

Sponsor
Hospital La Paz Institute for Health Research
Start
May 2014
Primary completion
Oct 2015
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of dobutamine in hemodynamic instability, sponsored by Hospital La Paz Institute for Health Research. Started May 2014; status: terminated.

02

Drugs

dobutamine
03

Conditions

hemodynamic instability

Beyond the preview

Go deeper on NCT03311178.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03311178.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call